Equity Profile

LNTH

Lantheus Holdings, Inc.

Health CareHealth Care Supplies$6.9B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Lantheus Holdings, Inc. is a healthcare company focused on developing and commercializing innovative diagnostic imaging agents and therapeutics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

N/A

Revenue Growth

Revenue growth will indicate the company's ability to expand its market presence and product adoption.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

LNTH Q2-2026 Earnings Preview

Context

Company Snapshot

Lantheus Holdings, Inc. is a healthcare company focused on developing and commercializing innovative diagnostic imaging agents and therapeutics. With a market cap of $7 billion, it plays a crucial role in the health care supplies sector, particularly in areas like cancer diagnostics and treatment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+24.91%

Avg Stock Reaction

-7.68%

Last Quarter Recap

In Q1 2026, Lantheus reported an EPS of $1.46, significantly beating expectations by 43.14%. The stock reacted positively, gaining 5.63% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Lantheus has consistently beaten EPS estimates in the past, but revenue guidance remains uncertain.

Bull Case

If Lantheus continues its trend of exceeding EPS estimates, it could see a strong stock performance, especially if revenue growth is also robust.

Bear Case

Conversely, if the company fails to maintain its earnings momentum or if there are signs of slowing revenue growth, it could lead to a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this will be a key indicator of ongoing profitability.

How is revenue growth trending compared to previous quarters?

Investors will be looking for signs of sustained growth or any potential slowdown in revenue, which could impact future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Lantheus's ability to sustain its earnings growth despite potential revenue challenges.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational efficiency.

Options pricing suggests lower volatility than historical averages, which may not reflect actual market sentiment.

Recent trends in the healthcare sector indicate a growing demand for diagnostic imaging solutions.

Key Risk

If EPS comes in below $1.30, it could undermine confidence in the company's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to maintain its earnings momentum and revenue growth.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case.

Bear Confirmed If

An EPS below $1.30 would signal a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±7.36%

Historical Avg

±13.2%

Pricing cheap

The options market is pricing in a move of about 7.36%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±7.4% while LNTH has averaged ±13.2% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.4%

30d HV

41.0%

Calls (2K)P/C Ratio: 0.48Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Lantheus beats expectations, history suggests a potential stock increase of around 7.68%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience muted movement as investors reassess growth prospects.

Miss

Should the company miss expectations, history suggests a potential decline of around 6.19%, leading to increased scrutiny of its growth strategy.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Insights into market demand for diagnostic imaging solutions.
3Management's commentary on competitive pressures and market share.
4Details on cost management strategies and operational efficiencies.
5Guidance on future revenue expectations and growth initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Lantheus Holdings, Inc. is a healthcare company focused on developing and commercializing innovative diagnostic imaging agents and therapeutics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

N/A

Revenue Growth

Revenue growth will indicate the company's ability to expand its market presence and product adoption.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

LNTH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+24.91%

Avg Stock Reaction

-7.68%

Last Quarter Recap

In Q1 2026, Lantheus reported an EPS of $1.46, significantly beating expectations by 43.14%. The stock reacted positively, gaining 5.63% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Lantheus has consistently beaten EPS estimates in the past, but revenue guidance remains uncertain.

Bull Case

If Lantheus continues its trend of exceeding EPS estimates, it could see a strong stock performance, especially if revenue growth is also robust.

Bear Case

Conversely, if the company fails to maintain its earnings momentum or if there are signs of slowing revenue growth, it could lead to a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this will be a key indicator of ongoing profitability.

How is revenue growth trending compared to previous quarters?

Investors will be looking for signs of sustained growth or any potential slowdown in revenue, which could impact future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Lantheus's ability to sustain its earnings growth despite potential revenue challenges.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational efficiency.

Options pricing suggests lower volatility than historical averages, which may not reflect actual market sentiment.

Recent trends in the healthcare sector indicate a growing demand for diagnostic imaging solutions.

Key Risk

If EPS comes in below $1.30, it could undermine confidence in the company's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to maintain its earnings momentum and revenue growth.

Bull Confirmed If

An EPS of $1.60 or higher would confirm the bull case.

Bear Confirmed If

An EPS below $1.30 would signal a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±7.36%

Historical Avg

±13.2%

Pricing cheap

The options market is pricing in a move of about 7.36%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±7.4% while LNTH has averaged ±13.2% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.4%

30d HV

41.0%

Calls (2K)P/C Ratio: 0.48Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Lantheus beats expectations, history suggests a potential stock increase of around 7.68%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience muted movement as investors reassess growth prospects.

Miss

Should the company miss expectations, history suggests a potential decline of around 6.19%, leading to increased scrutiny of its growth strategy.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Insights into market demand for diagnostic imaging solutions.
3Management's commentary on competitive pressures and market share.
4Details on cost management strategies and operational efficiencies.
5Guidance on future revenue expectations and growth initiatives.